Pulmonary Blood Flow Measurements in CHF Patients
Evaluation of Pulmonary Blood Flow Patterns Using Transthoracic Doppler in Patients With Congestive Heart Failure
Sponsor: Echosense Ltd.
Terminated
Changing staff
Other terminated trials from Echosense Ltd.
- Pulmonary Hypertension · Jul 2021
- ADHF · Phase NA · Jul 2021
- Pulmonary Embolism · Phase NA · Jan 2019
- Pulmonary Hypertension · Feb 2017
- Pulmonary Hypertension · Phase NA · Dec 2015
More terminations from Echosense Ltd.
Other Congestive Heart Failure (CHF) trials with similar outcome
This observational or N/A phase trial investigates Congestive Heart Failure (CHF) and is currently terminated or withdrawn. Echosense Ltd. leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Sep 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Echosense Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .